title: Assessment of hepatic function in cystic fibrosis by lidocaine metabolism.
abstract: BACKGROUND
  To determine hepatic drug metabolism in patients with cystic fibrosis, as measured by monoethylglycinexylidide formation after lidocaine injection and indocyanine green (ICG) clearance.
  
  
  METHODS
  The following study is a case-control study, which included 19 patients with cystic fibrosis and 13 control subjects. Serum monoethylglycinexylidide concentration was measured after intravenous injection of 1 mg/kg (maximum, 50 mg) lidocaine. Indocyanine green (0.5 mg/kg) was injected concomitantly, and absorbance (805 nm) of serum was measured over time to determine its volume of distribution, serum half-life, and hepatic blood flow.
  
  
  RESULTS
  Monoethylglycinexylidide formation was decreased in patients with cystic fibrosis compared with controls (39.4+/-16.9 microg/L versus 70.3+/-45.7 microg/L, mean +/- SD, respectively, P < 0.02). Indocyanine green half-life (4.6+/-2.7 min versus 3.0+/-1.0 min), volume of distribution (8.6+/-5.5 L versus 8.3+/-3.4 L), and hepatic blood flow (10.9+/-5.9 ml x kg(-1) x min(-1) versus 7.4+/-2.0 ml x kg(-1) x min(-1)) were similar in both groups.
  
  
  CONCLUSIONS
  Monoethylglycinexylidide formation after lidocaine injection is impaired in patients with cystic fibrosis. This impairment may have clinical implications when using hepatically metabolized medications in patients with cystic fibrosis.
authors.affiliation: The Department of Pediatrics, University of South Alabama College of Medicine, Mobile 36604, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Gremse
authors.forename: L J
authors.initials: LJ
authors.lastname: Sindel
authors.forename: C J
authors.initials: CJ
authors.lastname: Hoff
authors.forename: D J
authors.initials: DJ
authors.lastname: Wells
authors.forename: R C
authors.initials: RC
authors.lastname: Boerth
mesh_terms: D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D002648:Child; D003550:Cystic Fibrosis / Q000378:metabolism* / Q000503:physiopathology; D004395:Dye Dilution Technique; D005260:Female; D006207:Half-Life; D006801:Humans; D007208:Indocyanine Green / Q000378:metabolism; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000493:pharmacokinetics; D008099:Liver / Q000378:metabolism* / Q000503:physiopathology; D008102:Liver Circulation; D008111:Liver Function Tests; D008297:Male
chemical_list: D008012:Lidocaine; C001173:monoethylglycinexylidide; D007208:Indocyanine Green